Dolby Laboratories (DLB)
Return on equity (ROE)
| Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 200,656 | 184,087 | 310,227 | 231,363 | 255,151 |
| Total stockholders’ equity | US$ in thousands | 2,355,100 | 2,246,180 | 2,597,980 | 2,432,640 | 2,307,350 |
| ROE | 8.52% | 8.20% | 11.94% | 9.51% | 11.06% |
September 30, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $200,656K ÷ $2,355,100K
= 8.52%
The return on equity (ROE) for Dolby Laboratories has shown some fluctuation over the past five years. In Sep 30, 2023, the ROE stood at 8.52%, compared to 8.20% in Sep 30, 2022. This indicates a slight improvement in ROE from the previous year.
Looking further back, the ROE was 11.94% in Sep 30, 2021, which was relatively higher compared to the most recent figure. In Sep 30, 2020, the ROE was 9.51%, and in Sep 30, 2019, the ROE was 11.06%.
Overall, the trend in ROE for Dolby Laboratories shows some variability but has generally been within a relatively stable range over the past five years. It is important to delve deeper into the company's financial performance and factors influencing ROE to gain a more comprehensive understanding of its profitability and efficiency in generating returns for shareholders.
Peer comparison
Sep 30, 2023